Limited engraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice

Leukemia

Volumn 24, Issue 9, 2010, Pages 1662-1664

  Martin, M G ^a   Welch, J S ^a   Uy, G L ^a,b   Fehniger, T A ^a,b   Kulkarni, S ^a,b   Duncavage, E J ^a   Walter, M J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD34 ANTIBODY; CD45 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; B LYMPHOCYTE; BONE MARROW CELL; CELL CLONE; CELL COUNT; CELL EXPANSION; CELL INFILTRATION; CELL INTERACTION; CELL SURVIVAL; ENGRAFTMENT; FAILURE TO THRIVE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LETTER; MOUSE; MYELOBLAST; MYELODYSPLASTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; T CELL DEPLETION; TRISOMY 8; WEIGHT REDUCTION; WHOLE BODY RADIATION; XENOGRAFT; ANIMAL; GENETICS; KNOCKOUT MOUSE; NONOBESE DIABETIC MOUSE; PATHOLOGY; RISK ASSESSMENT; SCID MOUSE;

ANIMALS; HUMANS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MYELODYSPLASTIC SYNDROMES; RECEPTORS, INTERLEUKIN-2; RISK ASSESSMENT;

EID: 77956422816     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.156     Document Type: Letter

References (8)

1. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180-191.
2. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005; 174: 6477-6489.
3. Sanchez PV, Perry RL, Sarry JE, Perl AE, Murphy K, Swider CR et al. A robust xenotransplantation model for acute myeloid leukemia. Leukemia 2009; 23: 2109-2117.
4. Kim DK, Kojima M, Fukushima T, Miyasaka M, Nakauchi H. Engraftment of human myelodysplastic syndrome derived cell line in transgenic severe combined immunodeficient (TG-SCID) mice expressing human GM-CSF and IL-3. Eur J Haematol 1998; 61: 93-99.
5. Benito AI, Bryant E, Loken MR, Sale GE, Nash RA, John Gass M et al. NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors. Leuk Res 2003; 27: 425-436.
6. Thanopoulou E, Cashman J, Kakagianne T, Eaves A, Zoumbos N, Eaves C. Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome. Blood 2004; 103: 4285-4293.
7. Kerbauy DM, Lesnikov V, Torok-Storb B, Bryant E, Deeg HJ. Engraftment of distinct clonal MDS-derived hematopoietic precursors in NOD/SCID-beta2- microglobulin-deficient mice after intramedullary transplantation of hematopoietic and stromal cells. Blood 2004; 104: 2202-2203.
8. Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol 2010; 28: 275-280.